Qiagen Launches QuantiFERON SARS-CoV-2 RUO Solution for COVID-19

Share this

Qiagen Launches QuantiFERON SARS-CoV-2 RUO Solution for COVID-19


  • Qiagen launches QuantiFERON SARS-CoV-2 RUO solution that detects T-cell responses of the human immune system to the pathogen for COVID-19
  • Studies suggested that T-cell response to SARS-CoV-2 declines more slowly than Ab response presenting benefits to a researcher who wants to push beyond the existing detection of active infections to screen for potential courses of the illness and long-term immune responses to it
  • QuantiFERON SARS-CoV-2 RUO is a flexible- modular system designed to meet a wide range of research demands and is based on QuantiFERON technology

 ­ Ref: Businesswire | Image: Qiagen Corporate

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions